https://sputnikglobe.com/20240622/cancer-vaccine-trials-on-volunteers-to-begin-by-mid-2025---microbiology-center-director-1119056165.html
Cancer Vaccine Trials on Volunteers to Begin by Mid-2025 - Microbiology Center Director
Cancer Vaccine Trials on Volunteers to Begin by Mid-2025 - Microbiology Center Director
Sputnik International
Clinical trials of a cancer vaccine on patients are scheduled to begin by mid-2025, Alexander Gintsburg, the director of the Gamaleya National Research Center for Epidemiology and Microbiology, told Sputnik.
2024-06-22T02:05+0000
2024-06-22T02:05+0000
2024-06-22T02:05+0000
russia
russia
alexander gintsburg
cancer
cancer treatment
lung cancer
gamaleya research institute of epidemiology and microbiology
https://cdn1.img.sputnikglobe.com/img/07e4/08/0c/1080148259_0:0:2904:1634_1920x0_80_0_0_b70357d15b8fe9ac1a96a1ef9e567a9c.jpg
“I think that by the middle of next year we will begin clinical trials of the vaccine with the participation of patients with cancer,” Gintsburg said.He noted that now the vaccine is being tested in preclinical studies on mice, and the technology is being developed to not just extend the life of animals with melanoma by 2-3 times, but to create such drugs that would allow for guaranteed destruction of both the tumor and metastases.According to Gintsburg, if it is possible to work out this technology, the vaccine will help patients with non-small cell lung cancer, pancreatic cancer, certain types of kidney cancer, melanomas. Moreover, in these diseases metastases appear at early stages, so this vaccine will be very relevant for these patients, the specialist explained.
https://sputnikglobe.com/20240321/russian-doctors-remove-170-lung-cancer-tumors-breaking-world-record-1117464368.html
russia
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2024
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
gamaleya national research center for epidemiology and microbiology, russian cancer treatment, russian cancer vaccine, clinical trials cancer vaccine
gamaleya national research center for epidemiology and microbiology, russian cancer treatment, russian cancer vaccine, clinical trials cancer vaccine
Cancer Vaccine Trials on Volunteers to Begin by Mid-2025 - Microbiology Center Director
MOSCOW (Sputnik) - Clinical trials of a cancer vaccine on patients with cancer are scheduled to begin by mid-2025, Alexander Gintsburg, the director of the Moscow-based Gamaleya National Research Center for Epidemiology and Microbiology, told Sputnik.
“I think that by the middle of next year we will begin clinical trials of the vaccine with the participation of patients with cancer,” Gintsburg said.
He noted that now the vaccine is being tested in preclinical studies on mice, and the technology is being developed to not just extend the life of animals with melanoma by 2-3 times, but to create such drugs that would allow for guaranteed destruction of both the tumor and metastases.
According to Gintsburg, if it is possible to work out this technology, the vaccine will help patients with non-small cell lung cancer, pancreatic cancer, certain types of kidney cancer, melanomas. Moreover, in these diseases metastases appear at early stages, so this vaccine will be very relevant for these patients, the specialist explained.
